SCHEMBL8199342

SCHEMBL8199342

Bc1cnc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 2/20 0.61
MAP4K4 O95819 2/20 0.61
RET P07949 2/20 0.61
PIM1 P11309 2/20 0.61
KDR P35968 2/20 0.61
GSK3A P49840 2/20 0.61
GSK3B P49841 2/20 0.61
RPS6KA3 P51812 2/20 0.61
CDK5 Q00535 2/20 0.61
MAP4K2 Q12851 2/20 0.61
AURKB Q96GD4 2/20 0.61
CLK4 Q9HAZ1 2/20 0.61
TYRO3 Q06418 2/20 0.61
DYRK1B Q9Y463 2/20 0.61
AURKA O14965 1/20 0.61
DAPK3 O43293 1/20 0.61
JAK2 O60674 1/20 0.61
PAK4 O96013 1/20 0.61
ABL1 P00519 1/20 0.61
NTRK1 P04629 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481676 0.76 DYRK1A (1.00) PRKD3MAP4K4RETPIM1KDR
SCHEMBL31425375 0.76 PRKD3 (0.61) PRKD3MAP4K4RETPIM1KDR
SCHEMBL13564022 0.76 PRKD3 (0.61) PRKD3MAP4K4RETPIM1KDR
SCHEMBL6421058 0.76 RPS6KA3 (0.61) PRKD3MAP4K4RETPIM1KDR
SCHEMBL23773948 0.72 PRKD3 (0.56) PRKD3MAP4K4RETPIM1KDR
SCHEMBL13436519 0.72 MAP4K4 (0.56) PRKD3MAP4K4RETPIM1KDR
SCHEMBL6813381 0.72 PRKD3 (0.56) PRKD3MAP4K4RETPIM1KDR
SCHEMBL6752821 0.72 PRKD3 (0.56) PRKD3MAP4K4RETPIM1KDR
SCHEMBL19707188 0.71 PRKD3 (0.54) PRKD3MAP4K4RETPIM1KDR
SCHEMBL29650346 0.71 PRKD3 (0.54) PRKD3MAP4K4RETPIM1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457913-A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Signal Pharmaceuticals LLC (US) 2012-05-30 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed